Beiersdorf (XTRA:BEI) is back on investors’ radar after reporting half year 2026 results that showed slightly lower sales but broadly stable profitability compared with 2025, alongside the completion of a previously announced share buyback tranche.
See our latest analysis for Beiersdorf.
Beiersdorf’s share price closed at €77.0 and has fallen 17.04% on a year to date basis, while the 1 year total shareholder return declined 24.15%. However, the 90 day share price return gained 6.94%, which hints at momentum starting to rebuild following the half year results and buyback completion.
If Beiersdorf’s recent move has you thinking about what else is changing in consumer and industrial supply chains, it can be useful to scan 108 top founder-led companies
Beiersdorf now trades at a discount to both analyst targets and an estimated intrinsic value, even after the recent rebound. Is the market fairly cautious given the softer sales trend, or overly pessimistic about a steady earnings profile?
At a last close of €77.0 versus a narrative fair value around €86.1, Beiersdorf is framed as modestly undervalued. That gap hinges on how its product and market plans play out over the next few years.
Breakthrough innovation in science-based skincare, particularly the global rollout of the Epicelline anti-aging ingredient under both Eucerin and NIVEA, positions Beiersdorf to capture increased demand from an aging, health-conscious population, driving higher-margin revenue growth from both premium and mass-market channels.
Want to see what kind of revenue path, margin profile and future earnings multiple are baked into that fair value for Beiersdorf? The narrative leans on measured growth, small margin shifts and a specific valuation hurdle that has to be met years out, along with share count assumptions that quietly support the per share maths. The full story joins those moving parts into a single view of what the stock might be worth.
Result: Fair Value of €86.05 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the Beiersdorf narrative still faces real tests, including pressure from retailer negotiations in Europe and weaker progress in higher margin luxury and US premium brands.
Find out about the key risks to this Beiersdorf narrative.
The earlier narrative framed Beiersdorf as undervalued using fair value estimates around €86 per share. The P/E picture is less generous. At 17.9x earnings, the stock trades slightly above the European Personal Products industry at 17.1x, and above a fair ratio of 15.9x that the market could move towards. That leaves less obvious cushion if sentiment weakens.
For a closer look at what current earnings multiples might imply over the longer term, it is worth examining the valuation breakdown in more detail, including how Beiersdorf screens against peers on quality and pricing power. See what the numbers say about this price — find out in our valuation breakdown.
With mixed signals around Beiersdorf’s recent share price and valuation, it helps to move quickly and pressure test the upside case yourself. Start by weighing the 3 key rewards
If Beiersdorf has sharpened your focus on quality, do not stop here. Broader ideas from the Simply Wall St screener can help you stress test and refine your portfolio thinking.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com